Skip to content

A Comparison of Factors of Symptoms Generation and Evaluation of Role of Biofeedback in Patients With Different Types of Functional Esophageal Disorders (Functional Heartburn and Functional Chest Pain)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00471796
Enrollment
Unknown
Registered
2007-05-10
Start date
Unknown
Completion date
Unknown
Last updated
2007-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Pain, Heartburn

Keywords

Patients with functional chest pain and functional heartburns

Brief summary

There is supposed that patients with functional esophageal disorders such as functional heartburns and functional chest pain have common underlying mechanisms of symptom generation. These include esophageal dysmotility, non-acidic gastro-esophageal reflux, duodeno-gastro-esophageal reflux, esophageal hypersensitivity, and psychological comorbidity. The treatment of these patients is the growing challenge in the primary care medicine and in the gastroenterological practice. It was postulated that functional disorders of the esophagus are the main reason for PPI failure in patients with heartburn. The aim of the study is to evaluate the role of biofeedback in the treatment of patients with functional chest pain and functional heartburns.

Interventions

BEHAVIORALBiofeedback

Sponsors

Assaf-Harofeh Medical Center
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years

Inclusion criteria

1. Men and women ages 18-75. 2. Willing to participate and sign an inform consent. 3. Having heartburns, acid regurgitations and/or chest pain at least twice a week for at least 3 months. 4. Ability to stop anti-acid and anti-pain medications for at least two weeks.

Exclusion criteria

1. History of upper gastrointestinal surgery. 2. Concomitant diseases that may affect esophageal perception (diabetes mellitus, neuropathy). 3. Concomitant medications that may affect esophageal perception (anti-inflammatory, anti-depressants drugs). 4. Pregnancy. 5. Severe conditions such as cardiac failure, renal failure and other that may be contraindication for upper endoscopy. 6. Erosive esophagitis on upper endoscopy or pathological result of ambulatory 24-hour pH monitoring.

Contacts

Primary ContactMichael Shapiro, MD
shapirom1@yahoo.com+972-8-9779720

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026